Analyst picks & changes

AutoImmune Inc.

(AIMM)

Business: Autoimmune

Dillon, Read analyst Michael King began coverage of the Lexington, Mass., company with a "buy." Positive data on a Phase II trial of

Read the full 289 word article

How to gain access

Continue reading with a
two-week free trial.